The BioAssay network and its implications to future therapeutic discovery

BackgroundDespite intense investment growth and technology development, there is an observed bottleneck in drug discovery and development over the past decade. NIH started the Molecular Libraries Initiative (MLI) in 2003 to enlarge the pool for potential drug targets, especially from the “undruggable” part of human genome, and potential drug candidates from much broader types of drug-like small molecules. All results are being made publicly available in a web portal called PubChem.ResultsIn this paper we construct a network from bioassay data in PubChem, apply network biology concepts to characterize this bioassay network, integrate information from multiple biological databases (e.g. DrugBank, OMIM, and UniHI), and systematically analyze the potential of bioassay targets being new drug targets in the context of complex biological networks. We propose a model to quantitatively prioritize this druggability of bioassay targets, and literature evidence was found to confirm our prioritization of bioassay targets at a roughly 70% accuracy.ConclusionsOur analysis provide some measures of the value of the MLI data as a resource for both basic chemical biology research and future therapeutic discovery.

[1]  A. Barabasi,et al.  Drug—target network , 2007, Nature Biotechnology.

[2]  I. Kola,et al.  Can the pharmaceutical industry reduce attrition rates? , 2004, Nature Reviews Drug Discovery.

[3]  Inder M. Verma,et al.  The NIH Roadmap , 2004 .

[4]  T. Kennedy.  Managing the drug discovery/development interface , 1997 .

[5]  Van V. Brantner,et al.  Estimating the cost of new drug development: is it really 802 million dollars? , 2006, Health affairs.

[6]  Richard R. Neubig,et al.  Regulators of G-Protein signalling as new central nervous system drug targets , 2002, Nature Reviews Drug Discovery.

[7]  David S. Wishart,et al.  DrugBank: a knowledgebase for drugs, drug actions and drug targets , 2007, Nucleic Acids Res..

[8]  L. Pedersen,et al.  Substrate Gating Confers Steroid Specificity to Estrogen Sulfotransferase* , 1999, The Journal of Biological Chemistry.

[9]  H. Lehrach,et al.  A Human Protein-Protein Interaction Network: A Resource for Annotating the Proteome , 2005, Cell.

[10]  Guo-xi Xie,et al.  RGS Proteins: New Players in the Field of Opioid Signaling and Tolerance Mechanisms , 2005, Anesthesia and analgesia.

[11]  E. Zerhouni.  The NIH Roadmap , 2003, Science.

[12]  A. Barabasi,et al.  Hierarchical Organization of Modularity in Metabolic Networks , 2002, Science.

[13]  Albert,et al.  Emergence of scaling in random networks , 1999, Science.

[14]  Andrey Rzhetsky,et al.  Emergent behavior of growing knowledge about molecular interactions , 2005, Nature Biotechnology.

[15]  Erich E. Wanker,et al.  UniHI 4: new tools for query, analysis and visualization of the human protein–protein interactome , 2008, Nucleic Acids Res..

[16]  Mark W. Richards,et al.  Insights into the Conformational Variability and Regulation of Human Nek2 Kinase , 2009, Journal of molecular biology.

[17]  F. Sams-Dodd.  Target-based drug discovery: is something wrong? , 2005, Drug discovery today.

[18]  A. Barabasi,et al.  The human disease network , 2007, Proceedings of the National Academy of Sciences.

[19]  Erich E. Wanker,et al.  UniHI: an entry gate to the human protein interactome , 2006, Nucleic Acids Res..

[20]  M. DePamphilis,et al.  HUMAN DISEASE , 1957, The Ulster Medical Journal.

[21]  Chun-Fang Huang,et al.  Pathogenic Huntingtin Inhibits Fast Axonal Transport by Activating JNK3 and Phosphorylating Kinesin , 2009, Nature Neuroscience.

[22]  Tak-Hong Cheung,et al.  Transcriptional repression of WEE1 by Kruppel-like factor 2 is involved in DNA damage-induced apoptosis , 2005, Oncogene.

[23]  Judith A. Blake,et al.  The Mouse Genome Database (MGD): from genes to mice—a community resource for mouse biology , 2004, Nucleic Acids Res..

[24]  Jürgen Borlak,et al.  RSK4 and PAK5 Are Novel Candidate Genes in Diabetic Rat Kidney and Brain , 2005, Molecular Pharmacology.

[25]  Claudine Médigue,et al.  MICheck: a web tool for fast checking of syntactic annotations of bacterial genomes , 2005, Nucleic Acids Res..

[26]  David S. Wishart,et al.  DrugBank: a comprehensive resource for in silico drug discovery and exploration , 2005, Nucleic Acids Res..

[27]  T. Insel,et al.  NIH Molecular Libraries Initiative , 2004, Science.

[28]  Alan F. Scott,et al.  Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders , 2002, Nucleic Acids Res..

[29]  Brenda F Baker,et al.  Enhancement of SMN2 Exon 7 Inclusion by Antisense Oligonucleotides Targeting the Exon , 2007, PLoS biology.